Skip to main content
. 2017 Mar 17;8(19):31415–31423. doi: 10.18632/oncotarget.16329

Figure 1. Detection of DUS4L-BCAP29 in non-cancer human tissues and cell lines.

Figure 1

(A) Detection of the DUS4L-BCAP29 in several non-cancer human tissues by RT-PCR and followed by agarose electrophoresis. GAPDH was used as internal control. (B) Detection of the DUS4L-BCAP29 in several non-cancer cell lines by RT-PCR and followed by agarose electrophoresis. GAPDH was used as internal control. (C) Sanger sequencing validation of the RT-PCR product. Red line marks the fusion junction site.